KALVKalvista Pharmaceuticals Inc

NASDAQ · Biotechnology · Biotechnology

$19.08+20.00%Market cap1.02B
Latest Close
$19.08
30-Day Move
+20.0%
Market Cap
$1.0B
Shares Outstanding
50,550,000
P/B Ratio
7.18
ROE
-61.3%

Analyst consensus: Buy · 15 analysts

NASDAQ:KALVBiotechnology / BiotechnologyDelayed public snapshot

Kalvista Pharmaceuticals Inc

A read-only Alphactor snapshot forKalvista Pharmaceuticals Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.

Snapshot as of2026-04-23

Topline snapshot

Latest Close

$19.08

30-Day Move

+20.0%

Market Cap

$1.0B

Shares Outstanding

50,550,000

P/B Ratio

7.18

ROE

-61.3%

Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot

$19.08

+20.0%last 90 delayed daily bars

Market cap$1.0B

90D High

$21.30

90D Low

$14.22

Avg Volume

1,072,590

What stands out

Gross margin is running at 93.7%, which gives a quick read on operating quality before you open the full model.

Net margin is -119.2%, useful for comparing KALV against peers in Biotechnology.

KALV is up 20.0% over the last 30 trading days shown on this page.

Research snapshot

Dark Pool Short %

59.1%

Fundamentals snapshot

Latest Close

$19.08

30-Day Move

+20.0%

Market Cap

$1.0B

Shares Outstanding

50,550,000

P/B Ratio

7.18

ROE

-61.3%

ROA

-32.7%

Gross Margin

93.7%

Operating Margin

-123.5%

Net Margin

-119.2%

Debt / Equity

1.11

Current Ratio

5.58

Financial statement snapshot

Revenue

--

Gross Profit

--

Operating Income

--

Net Income

--

Gross Margin

9372.0%

Net Margin

-11917.0%

Current Ratio

5.58

Debt / Equity

1.11

Quality snapshot

Altman Z

--

N/A

Piotroski

0

Insufficient data

Cash Conversion

--

Rule of 40

--

Insufficient data

ETF holders snapshot
ETFSharesWeightAs Of
SmallCap World Fund Inc2,808,5830.05%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1,349,8510.03%2025-12-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1,127,9560.02%2026-03-31
iShares Trust-iShares Russell 2000 ETF928,9700.02%2026-02-28
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund427,9760.01%2025-12-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund371,4270.01%2026-01-31
iShares Trust-iShares Russell 2000 Growth ETF325,6880.01%2026-02-28
Principal Funds, Inc-SmallCap Growth Fund I322,5650.01%2026-01-31

After signup

The deeper ownership view shows who is leaning in

Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.

Use those ownership shifts alongside conviction and alerts in the full app workflow.

Sign up to open holder detail
Institutional holders snapshot

Qube Research & Technologies

Filed 2025-05-15

--

--

D.E. Shaw

Filed 2026-02-17

--

--

Two Sigma Advisers

Filed 2025-05-15

--

--

Vanguard Group

Filed 2026-01-29

$41M

+0.3%

BlackRock

Filed 2024-08-13

$35M

--

Geode Capital Management

Filed 2026-02-09

$15M

+1.7%

Goldman Sachs

Filed 2026-02-10

$13M

-53.6%

Dark-pool activity snapshot
Analyst consensus?
Rating(?)

4.33

Consensus

Buy
Target Mean(?)

Target High(?)

Target Low(?)

Analysts

15

Premium previews

See where the deeper analysis goes next

Sign up free
Open a preview card to sample a premium module.

High-intent actions

What you can do after signup

Organic traffic stays on the free tier by default, but signing up lets you save work and continue exploring.

For informational and educational purposes only. Not financial advice. Learn more

For informational and educational purposes only. Not financial advice. Learn more